<PAGE>
================================================================================
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
--------------------
FORM 15
Certification and Notice of Termination of Registration under Section 12(g)
of the Securities Exchange Act of 1934 or Suspension of Duty
to File Reports Under Sections 13 and 15(d) of the
Securities Exchange Act of 1934
Commission File No. 0-21721
CLINICOR, INC.
(Exact name of registrant as specified in charter)
1717 West Sixth Street, Suite 400, Austin, Texas 78703 (512) 344-3300
(Address, including zip code, and telephone number, including area code, of
registrant's principal executive offices)
Common Stock, $.001 par value
(Title of each class of securities covered by this Form)
None
(Titles of all other classes of securities for which a duty to file reports
under Section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule provision(s)
relied upon to terminate or suspend the duty to file reports:
Rule 12g-4(a)(1)(i) [X] Rule 12h-3(b)(1)(ii) [_]
Rule 12g-4(a)(1)(ii) [_] Rule 12h-3(b)(2)(i) [_]
Rule 12g-4(a)(2)(i) [_] Rule 12h-3(b)(2)(ii) [_]
Rule 12g-4(a)(2)(ii) [_] Rule 15d-6 [_]
Rule 12h-3(b)(1)(i) [_]
Approximate number of holders of record as of the certification or notice date:
36
---
Pursuant to the requirements of the Securities Exchange Act of 1934, Clinicor,
Inc. has caused this certification/notice to be signed on its behalf by the
undersigned duly authorized person.
CLINICOR, INC.
Date September 14, 2000 By /s/ Robert S. Sammis
-------------------------------------
___ Robert S. Sammis
President
(Principal Executive Officer)
